OasisLMS

WS01 - Humans Helping Humans: Overcoming Compassion Fatigue and Building Resilience in Oncology Care

WS02 - Personalizing Approaches to SCLC: Translating New Understandings of SCLC Heterogeneity into Biomarker-driven Small Cell Lung Cancer Therapies

WS03.01 - Early Career Investigator Workshop - Part 1

WS04 - Joint IASLC-CSCO-CAALC Session: Global Perspectives in Lung Cancer Treatment: Tackling Real-World Challenges Together

WS05 - IASLC / iMig Workshop

WS07 - Implication of the New TNM on the Management of Thymic Malignancies

WS08 - Practical Application of Gene-Editing for the Verification of Novel Lung Cancer Biomarkers: From Gene Discovery to Pre-clinical and Beyond

Awards Luncheon (First-Come First-Served)

WS03.02 - Early Career Investigator Workshop - Part 2

WS09 - IASLC & ITONF: Nurse & AHP Workshop

WS10 - Debates, Discussions & Didactics on Science Communications in 2025

WS11 - AI Usage for Radiation Oncology: Where Are We and Where Will We Go?

WS12 - GGO Management and Treatment – Intraoperative Electromagnetic Navigation Bronchoscopy (ENB) Guided Marking and Minimally Invasive Resection

WS03.03 - Early Career Investigator Workshop - Part 3

WS13 - LATAM Workshop

WS14 - From Guidelines to Implementation in NSCLC: Pertinent Considerations of Adherence to Consensus Standards of Care in Clinical Practice

PL01 - Opening Plenary with Distinguished Service Award Presentations: Transforming Lung Cancer through Societal Progress (LIVESTREAMED)

PL02 - Presidential Symposium 1 with Lectureship Award Presentations (LIVESTREAMED)

SS02 - Announcing the IASLC–Lancet Commission on Lung Cancer: A Transformative Global Approach

ES01 - Immunotherapy Partners: Exciting and Challenging Relationships

ES02 - Using Preclinical Models To Tackle the Therapeutic Challenges in Lung Cancer

ES03 - SCLC: The Knowns and Unknowns in Everyday Practice with Expert Insights

ES04 - Joint IASLC - GLCC Advocacy Session: Overcoming Challenges to Ensure Better Outcomes for People Living with Lung Cancer

ES05 - How We Do Lung Cancer Screening

HOW01 - Radiation Oncology Contouring Workshop - Locally Advanced NSCLC #1 (Pre-Sign Up Required for Case Assignments)

MA01 - New Drugs and Strategies in Locally Advanced NSCLC

MA02 - New Treatment Strategies in Other Than EGFR-Positive Tumors

OA01 - Smoking and Beyond: Navigating Risk Factors in Lung Cancer

OA02 - Latest Diagnostic and Management Options to Improve Survival Outcomes in Early-stage Resectable Non-small Cell Lung Cancer

DEI01 - Navigating Gender Equity in the Daily Life of a Thoracic Oncologist

HW01 - Work-Life Harmony: Redefining Balance in the Demanding Field of Oncology

SS03 - What Do This Year’s Policy Developments in Lung Cancer Mean for You?

ES07 - Advanced EGFR Mutant NSCLC Treatment Opportunities and Leptomeningeal Disease in Oncogene Driven NSCLC

ES08 - Navigating the Spectrum of Oligometastatic Disease in NSCLC

ES09 - What are the Best Practices for Invasive Staging for NSCLC in the Era of Chemo-Immunotherapy?

ES10 - Navigating Multidisciplinary Care: The Power of Communication in a Patient’s Journey

ES11 - Optimal Management of Early Stage Pleural Mesothelioma - Case Scenerios and Innovative Management Strategies

ES12 - Vaping to Stop, Vaping to Start

HOW02 - *Repeat Session* Radiation Oncology Contouring Workshop - Locally Advanced NSCLC #2 (Pre-Sign Up Required for Case Assignments)

MA03 - New Advances in Circulating Biomarkers

OA03 - Unravelling Tumor Evolution and Boosting Immunotherapy Efficacy

OA04 - From AI to Psychosocial Support: New Frontiers in Lung Cancer Multidisciplinary Care

ES06 - Joint IASLC-ESTRO Session: Safety and Synergy of Radiotherapy in EGFR and ALK NSCLC

ES13 - How Well Do You Know Your ADCs?

ES14 - Multiomic Spatial Biology, Liquid Biopsy

ES15 - Local Interventions for Early Stage Non-Small Cell Lung Cancer

ES16 - Improving Outcomes From Lung Cancer Globally: Where Everyone’s Voice Matters

ES17 - Updates on Lung Cancer Pathology

ES18 - Navigating the Challenges of Locally Advanced NSCLC

OA05 - Immunotherapy for Special Populations

OA06 - Novel ADCs in SCLC

WS15 - Sybil: Using a Deep Learning Model to Predict Lung Cancer Risk in the Real World

PL03 - Presidential Symposium 2 with Lectureship Award Presentations (LIVESTREAMED)

SS04 - The WHO Integrated Lung Health Resolution: What it is and Why it Matters to the Lung Cancer Community

HOD01 - Highlights of the Day - Sunday Abstracts

ES19 - How To Improve Efficacy of Immunotherapy in Metastatic NSCLC?

ES20 - Leveraging Omics to Understand the Biology of Lung Cancer

ES21 - What We Need to Know About Lung Neuroendocrine Neoplasms (NENs): Insights from a Multidisciplinary Perspective

ES22 - Adding Value to Lung Cancer Care: Multidisciplinary Toxicity Management for New Therapies

ES23 - Enhancing the Efficiency and Quality in Screening Programs

ES24 - Joint IASLC - ASCO Session: Terminating Lung Cancer: Harnessing AI to Transform the Battle to Conquer Lung Cancer

HOW03 - Robotic Navigational Bronchoscopy Workshop #1 (Limited Capacity - First Come First Served)

MA04 - Multi-Modal Treatment of Resectable Lung Cancer - Outcomes of Targeted Treatments and Immunotherapies in Early-Stage Lung Cancer

OA07 - Expanding Horizons in Advanced NSCLC Integrating Local Therapy

OA08 - Improving Outcomes in EGFR and KRAS Mutant Tumours, More is Better?

ME01 - Meet the Editors

DEI02 - Inclusion in Action: Addressing Hidden and Emerging Inequities in Thoracic Oncology

IASLC Business Meeting (LIVESTREAMED)

ES25 - Oncogene Addicted NSCLC: Worldwide Case Based Discussions

ES26 - Oligometastatic Dilemmas: Real-World Cases, Insights, and Multidisciplinary Solutions

ES27 - Imaging Tools for Staging: New Kids on the Block

ES28 - Personalized Cancer Care: From Diagnosis to Survivorship

ES29 - Thymic Malignancies – How to Move the Field Forward

ES30 - Lung Cancer and Risk Factors: Exploring Beyond Cigarette Smoking

HOW04 - *Repeat Session* Robotic Navigational Bronchoscopy Workshop #2 (Limited Capacity - First Come First Served)

MA05 - Precision in Lung Cancer Screening

MA06 - Improving Care Judiciously

OA09 - New Advances in Pathology

OA10 - Optimizing Systemic Therapy: Bridging New and Old

ES31 - ADCs: Current Controveries

ES32 - Experimental Design for Dissecting Immune Evasion, Cell Plasticity, and Drug Resistance

ES33 - Precision Frontiers: Targeted Therapies in Early-stage Lung Cancer

ES34 - Narrowing Disparities for Effective Management of Lung Cancer on a Global Scale

ES35 - EGFR as a Biomarker: Past, Present, Future

ES36 - Stage III NSCLC: How Far Can We Push the Limits? Battle of Perspectives

OA11 - Beyond TNM - New Horizons in Prognostication

OA12 - Novel Clinical Approaches and Translational Investigation in Mesothelioma

OA13 - Optimizing Front-Line Treatment in SCLC

PL04 - Scientific Plenary with Lecturship Award Presentations: From Learners to Leaders: Advancing Oncology Training for the Next Generation of Thoracic Oncologists (LIVESTREAMED)

HOD02 - Highlights of the Day - Monday Abstracts

ES37 - Challenging Scenarios for Immunotherapy Treatment

ES38 - What Providers Need to Know to Personalize Care for Resectable Lung Cancer

ES39 - Breaking New Ground: Challenging Advances in SCLC Therapy

ES40 - Uniting Forces: Multidisciplinary Approaches to Holistic Lung Cancer Care

HOW05 - Next Generation Sequencing Clinical Report Decodification in Non-Small Cell #1 (Limited Capacity - First Come First Served)

MA07 - New Perspectives in Pathology Biomarkers

MA08 - Common and Uncommon EGFR Mutations, New Treatments in the Horizon

OA14 - Cancer Evolution and Drug Resistance

OA15 - Global Lung Cancer Screening Strategies

OA16 - Building Bridges Between Resectable and Unresectable Stage III NSCLC

ES41 - Challenges in Oncogene Driven NSCLC: Young Patients, Economic Toxicity, Feasibility for De-Escalating TKI

ES42 - Patient and Experts Dialogs for Neoadjuvant, Adjuvant or Perioperative Modalities for Resectable NSCLC

ES43 - Confounding Cases of Pulmonary Nodules: Advances in the Diagnosis and Management of Subsolid and Ground Glass Opacities

ES44 - Addressing Special Conditions to Bridge Gaps in Unresectable NSCLC

HOW06 - *Repeat Session* Next Generation Sequencing Clinical Report Decodification in Non-Small Cell Lung Cancer Lung Cancer #2 (Limited Capacity - First Come First Served)

MA09 - Diving Deep into Diversity: Old and New Risks for Lung Cancer

MA10 - Longer Follow Up and New IO Combinations 

MA11 - Innovative Therapeutic Strategies and Molecular Insights in SCLC and Neuroendocrine Tumors

OA17 - Balancing Cost, Care and Patient Choice in Real World Journey and Research

OA18 - The Best Road: Reducing Disparities and Improving Early Detection Rates

CL01 - Closing Lunch

HOD03 - Highlights of the Day - Tuesday Abstracts On-Demand

TEST01 - Test Session